-+ 0.00%
-+ 0.00%
-+ 0.00%

Moderna Raises 2026 Revenue Growth Outlook to 15-25% From Up to 10%

PUBT·11/12/2026 14:22:11
Moderna Raises 2026 Revenue Growth Outlook to 15-25% From Up to 10%
  • Moderna raised its 2026 revenue growth outlook to 15%-25%, exceeding its original forecast of up to 10%.
  • Strategic partnerships are expected to drive the majority of sales outside the U.S., providing recurring revenue under multiyear agreements.
  • Growth drivers for 2027 include the mFLUSIVA launch, European product approvals and partnerships in Mexico and Taiwan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moderna Inc. published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.